Close Menu

NEW YORK (GenomeWeb) – Mammoth Biosciences, a biotech startup cofounded by CRISPR researcher Jennifer Doudna, came out of stealth mode today by announcing a plan to develop a CRISPR-enabled platform capable of detecting any biomarker or disease containing DNA or RNA.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.